面向脊髓小脑共济失调3型的等位基因特异性靶向治疗与药效标志物
脊髓小脑共济失调3型(SCA3)由ATXN3基因CAG重复扩增致病,缺乏临床试验可用的药效标志物。该研究建立免疫检测法,可在人生物体液中检测多聚谷氨酰胺(polyQ)ATXN3蛋白,区分SCA3患者与健康对照及其他共济失调个体;并在人成纤维细胞中显示polyQ ATXN3可作为靶点结合标志物,还鉴定出与扩增等位基因强关联的单核苷酸多态性,为等位基因特异性药物靶点提供依据。
要点
- 免疫检测法可在人生物体液中检测polyQ ATXN3并区分SCA3患者。
- polyQ ATXN3在人成纤维细胞中可作为靶点结合的药效标志物。
- 鉴定出与扩增等位基因强关联的单核苷酸多态性,可作药物靶点。
核心结论
- polyQ ATXN3可作为SCA3临床试验的药效标志物,所鉴定的单核苷酸多态性为等位基因特异性靶向治疗提供候选靶点。
研究设计与样本
- 研究建立免疫检测法检测人生物体液中的polyQ ATXN3蛋白,并在人成纤维细胞中评估其作为靶点结合标志物的可行性。
主要发现
- 免疫检测法可区分SCA3患者与健康对照及其他共济失调个体。
- polyQ ATXN3在人成纤维细胞中可作为靶点结合标志物。
- 鉴定出与扩增等位基因强关联的单核苷酸多态性。
临床怎么用
- 该免疫检测法有望用于SCA3临床试验的患者筛选与靶点结合监测。
- 所鉴定单核苷酸多态性可支持开发等位基因特异性基因沉默治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Spinocerebellar ataxia type 3 (SCA3), caused by a CAG repeat expansion in the ataxin-3 gene (ATXN3), is characterized by neuronal polyglutamine (polyQ) ATXN3 protein aggregates. Although there is no cure for SCA3, gene-silencing approaches to reduce toxic polyQ ATXN3 showed promise in preclinical models. However, a major limitation in translating putative treatments for this rare disease to the clinic is the lack of pharmacodynamic markers for use in clinical trials. Here, we developed an immunoassay that readily detects polyQ ATXN3 proteins in human biological fluids and discriminates patients with SCA3 from healthy controls and individuals with other ataxias. We show that polyQ ATXN3 serves as a marker of target engagement in human fibroblasts, which may bode well for its use in clinical trials. Last, we identified a single-nucleotide polymorphism that strongly associates with the expanded allele, thus providing an exciting drug target to abrogate detrimental events initiated by mutant ATXN3. Gene-silencing strategies for several repeat diseases are well under way, and our results are expected to improve clinical trial preparedness for SCA3 therapies.
引用
- Prudencio M, Garcia-Moreno H, Jansen-West KR, et al. Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3. Sci Transl Med. 2020. PMID: 33087504. doi:10.1126/scitranslmed.abb7086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。